Skip to main content
. Author manuscript; available in PMC: 2016 Feb 15.
Published in final edited form as: Bioorg Med Chem Lett. 2014 Dec 22;25(4):919–924. doi: 10.1016/j.bmcl.2014.12.054

Table 1.

The PDE10A inhibition activity (IC50 nM) of cinnoline analogues

graphic file with name nihms651329u1.jpg
Compound# R3 R2 R3 R4 IC50 (nM)a
13a -OCH3 -OCH3 -H CH3 18.4 ± 6.0
13b -OBn -OCH3 -H CH3 4,250 ± 520
13c -OCH3 -OCH3 -H pyridin-3-yl 14.0 ± 2.0
13d -OBn -OCH3 -H pyridin-3-yl 1,550 ± 260
14a -OH -OCH3 -H CH3 10,800 ± 1,500
14b -OH -OCH3 -H pyridine-3-yl 6,620 ± 600
26a -OCH3 -OCH3 -CH3 pyridine-3-yl 1.52 ± 0.18
26b -OCH3 -OCH3 -CH3 2-fluoro-pyridin-5-yl 2.86 ± 0.10
26c -O-CH2-O- -CH3 2-fluoro-pyridin-5-yl NAb
26d -H -H -CH3 2-fluoro-pyridin-5-yl NAb
26e -OCH3 -OCH3 -CH3 2-chloro-pyridin-5-yl 9.8 ± 1.3
26f -OBn -OCH3 -CH3 2-fluoro-pyridin-5-yl 350 ± 23
26g -OCH3 -OCH3 -Cl pyridin-3-yl 5.52 ± 0.33
26h 2-(oxymethyl)-quinolinyl -OCH3 -CH3 2-fluoro-pyridin-5-yl 518 ± 86
26i fluoropropoxy -OCH3 -CH3 2-fluoro-pyridin-5-yl 79.3 ± 3.6
a

IC50 value (mean ± SD nM) were determined in at least three experiments;

b

NA = no inhibition activity